ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,915, issued on Oct. 7, was assigned to JJR&D LLC (Celina, Tenn.).

"Cancer cytotoxic exosome formulations and methods for use in treating cancer" was invented by Joaquin J. Jimenez (Miami) and John P. McCook (Frisco, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods for treating cancer, particularly leukemia, using a cytotoxic composition comprising monocytes activated by Beta-glucan. The monocytes are preferably incubated with the Beta-glucan and then processed to extract particles, such as microvesicles and exosomes from the treated monocytes to produce the cytotoxic composition. Preferably the cytotoxic composition compr...